Clinic marketing reports tend to be long and unhelpful. Impressions, reach, engagement, click-through rate, cost per click, page views. None of those numbers answer the only question the owner has, which is whether the money produced patients.
A stem cell clinic needs six metrics: cost per booked consult, show rate, close rate, average case value, patient acquisition cost, and return on ad spend measured against collected revenue. Everything else is diagnostic detail that belongs beneath those six, not alongside them.
The Six That Decide Everything
Cost per booked consult. Total spend divided by consultations actually on the calendar. This is the first honest checkpoint, because it filters out lead volume that never became a conversation.
Show rate. The percentage of booked consults that happen. The most ignored number in clinic marketing and usually the cheapest to improve.
Close rate. Of attended consults, the share that become paying patients. This is a sales metric, not a marketing one, and it moves acquisition cost more than any media decision.
Average case value. What patients actually pay after discounts, financing fees, and protocol mix.
Patient acquisition cost. All sales and marketing spend divided by patients who paid.
Return on ad spend against collected revenue. Not platform-reported conversion value. Money that arrived.
Together these six form a chain, and the chain is diagnostic. If revenue fell, exactly one link moved, and you can see which.
Why Platform Metrics Mislead
Ad platforms optimize toward what they can observe, which is clicks and form fills. That is not malicious, it is structural. But it means the metrics they surface most prominently are the ones least connected to your revenue.
A campaign can improve every platform metric while producing fewer patients: cheaper clicks from a less qualified audience, more form fills from people who will not qualify, better engagement from an audience that will never buy.
Use platform metrics to diagnose within a channel. Use revenue metrics to decide between channels. Confusing the two is how clinics end up scaling their worst performer.
Read the Chain, Not the Number
The value of tracking all six is that a revenue drop becomes an addressable problem rather than a mystery.
Cost per booked consult rose while show and close held: a traffic or offer problem. Consult cost held but show rate fell: a confirmation and scheduling problem. Show held but close fell: a sales, fit, or pricing problem. Everything held but revenue fell: case value dropped, usually from discounting or protocol mix.
Four different diagnoses, four different fixes, and none of them visible from a single top-line number. This is the practical argument for the whole framework in the stem cell marketing plan.
Set Targets Before You Report
A metric without a target is trivia. Each of the six needs a number the clinic is trying to hit, derived from your own economics rather than an industry benchmark.
Start from allowable acquisition cost, work backward through your close and show rates, and you arrive at a defensible target cost per booked consult. Now every channel report is a pass or fail rather than a discussion, and the weekly review takes minutes.
Review Weekly, Judge Quarterly
Review the six weekly to catch breaks early. A month is long enough to waste real money on a broken funnel.
But judge channel viability quarterly. Regenerative patients take weeks to decide, so a channel evaluated on thirty days of data will be judged before its patients have paid. Clinics that kill channels monthly tend to cycle through vendors while the underlying problem, usually downstream of the ad, stays exactly where it was.
Change one variable at a time between reviews. Simultaneous changes to creative, landing page, and follow-up produce a result you cannot attribute to anything.
What to Stop Reporting
Impressions and reach describe how many times a machine displayed something. Engagement describes whether people liked it. Click-through rate is useful inside a channel and meaningless across channels. Lead count without qualification actively misleads, because it rewards the campaigns that attract the least serious inquiries.
Move all of it into an appendix. The main report is six numbers, each against a target, each traced to collected revenue. That report fits on one page, and it is the one an owner can act on. Building the plumbing to produce it is covered in conversion tracking for stem cell clinics.
Frequently Asked Questions
What return on ad spend should a stem cell clinic target?
Derive it from your own margin rather than a benchmark. Once you know delivery cost and overhead, you can calculate the return required for a channel to be worth running. A clinic with high biologics cost needs a higher figure than a lean one at identical revenue.
How do we measure organic and referral alongside paid?
Capture source at intake for every patient regardless of channel, then compare blended acquisition cost across quarters. Organic and referral will not show a clean cost per acquisition, but their effect appears clearly in falling blended cost over time.
Our numbers swing wildly month to month. What are we doing wrong?
Usually nothing, if patient volume is low. At eight to twelve patients a month, one case moves every percentage materially. Use rolling ninety-day figures for decisions and reserve weekly review for spotting breaks rather than judging performance.
Who should own this report?
One person inside the clinic, not the agency. Agencies should report into it. When the vendor owns the scorecard, the scorecard tends to grade the vendor favorably.